The bevacizumab experience in advanced renal cell carcinoma

por Harshman, Lauren C, Srinivas, Sandy
Publicado 2010

Abiraterone Acetate: Targeting Persistent Androgen Dependence in Castration-Resistant Prostate Cancer

por Harshman, Lauren C., Taplin, Mary-Ellen
Publicado 2013

Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series

por Martini, Dylan J., Lalani, Aly-Khan A., Bossé, Dominick, Steinharter, John A., Harshman, Lauren C., Hodi, F. Stephen, Ott, Patrick A., Choueiri, Toni K.
Publicado 2017

Characterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-d...

por Kamran, Sophia C., Harshman, Lauren C., Bhagwat, Mandar S., Muralidhar, Vinayak, Nguyen, Paul L., Martin, Neil E., La Follette, Stephanie, Faso, Sarah, Viswanathan, Akila N., Efstathiou, Jason A., Beard, Clair J.
Publicado 2017

Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

por Nuzzo, Pier Vitale, Pond, Gregory R, Abou Alaiwi, Sarah, Nassar, Amin H, Flippot, Ronan, Curran, Catherine, Kilbridge, Kerry L, Wei, Xiao X, McGregor, Bradley A, Choueiri, Toni, Harshman, Lauren C, Sonpavde, Guru
Publicado 2020

Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma

por Bellmunt, Joaquim, Lalani, Aly-Khan A., Jacobus, Sussana, Wankowicz, Stephanie A., Polacek, Laura, Takeda, David Y., Harshman, Lauren C., Wagle, Nikhil, Moreno, Irene, Lundgren, Kevin, Bossé, Dominick, Van Allen, Eliezer M., Choueiri, Toni K., Rosenberg, Jonathan E.
Publicado 2018

Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression

por Lalani, Aly-Khan A., Gray, Kathryn P., Albiges, Laurence, Callea, Marcella, Pignon, Jean-Christophe, Pal, Soumitro, Gupta, Mamta, Bhatt, Rupal S., McDermott, David F., Atkins, Michael B., Woude, G.F. Vande, Harshman, Lauren C., Choueiri, Toni K., Signoretti, Sabina
Publicado 2017

Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma

por Lalani, Aly-Khan A., Xie, Wanling, Martini, Dylan J., Steinharter, John A., Norton, Craig K., Krajewski, Katherine M., Duquette, Audrey, Bossé, Dominick, Bellmunt, Joaquim, Van Allen, Eliezer M., McGregor, Bradley A., Creighton, Chad J., Harshman, Lauren C., Choueiri, Toni K.
Publicado 2018

Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma

por Abou Alaiwi, Sarah, Xie, Wanling, Nassar, Amin H, Dudani, Shaan, Martini, Dylan, Bakouny, Ziad, Steinharter, John A, Nuzzo, Pier Vitale, Flippot, Ronan, Martinez-Chanza, Nieves, Wei, Xiao, McGregor, Bradley A, Kaymakcalan, Marina D, Heng, Daniel Y C, Bilen, Mehmet A, Choueiri, Toni K, Harshman, Lauren C
Publicado 2020

Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival

por Ramos, Jorge D., Casey, Martin F., Crabb, Simon J., Bamias, Aristotelis, Harshman, Lauren C., Wong, Yu‐Ning, Bellmunt, Joaquim, De Giorgi, Ugo, Ladoire, Sylvain, Powles, Thomas, Pal, Sumanta K., Niegisch, Guenter, Recine, Federica, Alva, Ajjai, Agarwal, Neeraj, Necchi, Andrea, Vaishampayan, Ulka N., Rosenberg, Jonathan E., Galsky, Matthew D., Yu, Evan Y.
Publicado 2016

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer

por Rose, Tracy L., Deal, Allison M., Ladoire, Sylvain, Créhange, Gilles, Galsky, Matthew D., Rosenberg, Jonathan E., Bellmunt, Joaquim, Wimalasingham, Akhila, Wong, Yu-Ning, Harshman, Lauren C., Chowdhury, Simon, Niegisch, Guenter, Liontos, Michalis, Yu, Evan Y., Pal, Sumanta K., Chen, Ronald C., Wang, Andrew Z., Nielsen, Matthew E., Smith, Angela B., Milowsky, Matthew I.
Publicado 2016

Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database

por Del Bene, Gabriella, Calabrò, Fabio, Giannarelli, Diana, Plimack, Elizabeth R., Harshman, Lauren C., Yu, Evan Y., Crabb, Simon J., Pal, Sumanta Kumar, Alva, Ajjai S., Powles, Thomas, De Giorgi, Ugo, Agarwal, Neeraj, Bamias, Aristotelis, Ladoire, Sylvain, Necchi, Andrea, Vaishampayan, Ulka N., Niegisch, Günter, Bellmunt, Joaquim, Baniel, Jack, Galsky, Matthew D., Sternberg, Cora N.
Publicado 2018

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma

por Nassar, Amin H., Abou Alaiwi, Sarah, AlDubayan, Saud H., Moore, Nicholas, Mouw, Kent W., Kwiatkowski, David J., Choueiri, Toni K., Curran, Catherine, Berchuck, Jacob E., Harshman, Lauren C., Nuzzo, Pier V., Chanza, Nieves Martinez, Van Allen, Eliezer, Esplin, Edward D., Yang, Shan, Callis, Thomas, Garber, Judy E., Rana, Huma Q., Sonpavde, Guru
Publicado 2019

Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma

por Tripathi, Abhishek, Lin, Edwin, Xie, Wanling, Flaifel, Abdallah, Steinharter, John A, Stern Gatof, Emily N, Bouchard, Gabrielle, Fleischer, Justin H, Martinez-Chanza, Nieves, Gray, Connor, Mantia, Charlene, Thompson, Linda, Wei, Xiao X, Giannakis, Marios, McGregor, Bradley A, Choueiri, Toni K, Agarwal, Neeraj, McDermott, David F, Signoretti, Sabina, Harshman, Lauren C
Publicado 2020

A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma

por Nassar, Amin H., Mouw, Kent W., Jegede, Opeyemi, Shinagare, Atul B., Kim, Jaegil, Liu, Chia-Jen, Pomerantz, Mark, Harshman, Lauren C., Van Allen, Eliezer M., Wei, Xiao X., McGregor, Bradley, Choudhury, Atish D., Preston, Mark A., Dong, Fei, Signoretti, Sabina, Lindeman, Neal I., Bellmunt, Joaquim, Choueiri, Toni K., Sonpavde, Guru, Kwiatkowski, David J.
Publicado 2019

Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abirat...

por Francini, Edoardo, Montagnani, Francesco, Nuzzo, Pier Vitale, Gonzalez-Velez, Miguel, Alimohamed, Nimira S., Rosellini, Pietro, Moreno-Candilejo, Irene, Cigliola, Antonio, Rubio-Perez, Jaime, Crivelli, Francesca, Shaw, Grace K., Zhang, Li, Petrioli, Roberto, Bengala, Carmelo, Francini, Guido, Garcia-Foncillas, Jesus, Sweeney, Christopher J., Higano, Celestia S., Bryce, Alan H., Harshman, Lauren C., Lee-Ying, Richard, Heng, Daniel Y. C.
Publicado 2021

Metastatic renal cell carcinoma to the pancreas and other sites—a multicenter retrospective study

por Duarte, Cassandra, Hu, Junxiao, Beuselinck, Benoit, Panian, Justine, Weise, Nicole, Dizman, Nazli, Collier, Katharine A., Rathi, Nityam, Li, Haoran, Elias, Roy, Martinez-Chanza, Nieves, Rose, Tracy L., Harshman, Lauren C., Gopalakrishnan, Dharmesh, Vaishampayan, Ulka, Zakharia, Yousef, Narayan, Vivek, Carneiro, Benedito A., Mega, Anthony, Singla, Nirmish, Meguid, Cheryl, George, Saby, Brugarolas, James, Agarwal, Neeraj, Mortazavi, Amir, Pal, Sumanta, McKay, Rana R., Lam, Elaine T.
Publicado 2023

Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors

por Adalsteinsson, Viktor A., Ha, Gavin, Freeman, Samuel S., Choudhury, Atish D., Stover, Daniel G., Parsons, Heather A., Gydush, Gregory, Reed, Sarah C., Rotem, Denisse, Rhoades, Justin, Loginov, Denis, Livitz, Dimitri, Rosebrock, Daniel, Leshchiner, Ignaty, Kim, Jaegil, Stewart, Chip, Rosenberg, Mara, Francis, Joshua M., Zhang, Cheng-Zhong, Cohen, Ofir, Oh, Coyin, Ding, Huiming, Polak, Paz, Lloyd, Max, Mahmud, Sairah, Helvie, Karla, Merrill, Margaret S., Santiago, Rebecca A., O’Connor, Edward P., Jeong, Seong H., Leeson, Rachel, Barry, Rachel M., Kramkowski, Joseph F., Zhang, Zhenwei, Polacek, Laura, Lohr, Jens G., Schleicher, Molly, Lipscomb, Emily, Saltzman, Andrea, Oliver, Nelly M., Marini, Lori, Waks, Adrienne G., Harshman, Lauren C., Tolaney, Sara M., Van Allen, Eliezer M., Winer, Eric P., Lin, Nancy U., Nakabayashi, Mari, Taplin, Mary-Ellen, Johannessen, Cory M., Garraway, Levi A., Golub, Todd R., Boehm, Jesse S., Wagle, Nikhil, Getz, Gad, Love, J. Christopher, Meyerson, Matthew
Publicado 2017

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

por Bakouny, Ziad, Braun, David A., Shukla, Sachet A., Pan, Wenting, Gao, Xin, Hou, Yue, Flaifel, Abdallah, Tang, Stephen, Bosma-Moody, Alice, He, Meng Xiao, Vokes, Natalie, Nyman, Jackson, Xie, Wanling, Nassar, Amin H., Abou Alaiwi, Sarah, Flippot, Ronan, Bouchard, Gabrielle, Steinharter, John A., Nuzzo, Pier Vitale, Ficial, Miriam, Sant’Angelo, Miriam, Forman, Juliet, Berchuck, Jacob E., Dudani, Shaan, Bi, Kevin, Park, Jihye, Camp, Sabrina, Sticco-Ivins, Maura, Hirsch, Laure, Baca, Sylvan C., Wind-Rotolo, Megan, Ross-Macdonald, Petra, Sun, Maxine, Lee, Gwo-Shu Mary, Chang, Steven L., Wei, Xiao X., McGregor, Bradley A., Harshman, Lauren C., Genovese, Giannicola, Ellis, Leigh, Pomerantz, Mark, Hirsch, Michelle S., Freedman, Matthew L., Atkins, Michael B., Wu, Catherine J., Ho, Thai H., Linehan, W. Marston, McDermott, David F., Heng, Daniel Y. C., Viswanathan, Srinivas R., Signoretti, Sabina, Van Allen, Eliezer M., Choueiri, Toni K.
Publicado 2021